Hepatitis C virus utilizes VLDLR as a novel entry pathway.

Area of Science:

• Virology
• Cell Biology
• Hepatology

Background:

• Hepatitis C Virus (HCV) entry into host cells involves multiple cellular factors.
• CD81 is a well-established receptor mediating HCV cellular entry.
• Understanding alternative entry pathways is crucial for developing effective therapies.

Purpose of the Study:

• To identify novel host factors involved in Hepatitis C Virus (HCV) cellular entry.
• To investigate the role of the very-low-density lipoprotein receptor (VLDLR) in HCV entry.
• To determine if VLDLR-mediated HCV entry is independent of CD81.

Main Methods:

• Utilized Huh7.5 cells cultured under normoxic and hypoxic conditions.
• Assessed HCV entry in CD81-deficient cells with ectopic VLDLR expression.
• Performed knockdown experiments of known HCV receptors and entry factors.
• Confirmed VLDLR expression in primary human hepatocytes.

Main Results:

• Hypoxic conditions increased HCV entry in Huh7.5 cells due to VLDLR upregulation.
• Ectopic VLDLR expression enabled HCV entry in CD81-deficient cells.
• VLDLR-mediated HCV entry was not inhibited by the knockdown of known HCV factors.
• VLDLR is expressed in primary human hepatocytes.

Conclusions:

• The very-low-density lipoprotein receptor (VLDLR) mediates Hepatitis C Virus (HCV) entry independently of CD81.
• VLDLR represents a novel, CD81-independent pathway for HCV cellular entry.
• VLDLR's expression in primary hepatocytes suggests its role in vivo, offering a potential therapeutic target.